Eve Hutcherson on LinkedIn: Congratulations to my friends at Ardent Health Services for their… (2024)

Increasing regulation and competition, along with rising costs, have created a perfect storm for health care systems to join forces.The past couple of years saw Bellin Health of Green Bay and Gundersen Health System of La Crosse, as well as Appleton’s ThedaCare and Froedtert & the Medical College of Wisconsin health system of Milwaukee, combine their resources. Meanwhile, Aurora Health, which has clinics and hospitals throughout the region, completed a merger with Advocate Health Care before that company combined with Atrium Health.The health care industry overall is seeing more cross-market mergers. To learn why, pick up the April issue of Insight: https://loom.ly/Cjyc1aA

1

**Ardent CEO Plans Expansion Despite Downsized IPO**=====================================================Marty Bonick, CEO of Ardent Health Services, is focused on expanding the company despite a downsized initial public offering (IPO) earlier this year. In an interview with Modern Healthcare, Bonick stated that the company is still committed to its growth strategy, which includes expanding its presence in the healthcare market.Ardent Health Services is a leading provider of healthcare services, with a portfolio of hospitals and medical facilities across the United States. The company went public in March with an IPO that raised $120 million, which was less than the expected $150 million.Despite the downsized IPO, Bonick remains optimistic about the company's future prospects. He cited the company's strong financial performance, its commitment to quality patient care, and its strategic partnerships with other healthcare providers as key factors that will drive growth."We are committed to delivering high-quality patient care and creating value for our patients, physicians, and employees," Bonick said. "We are confident that our growth strategy will enable us to achieve our goals and create long-term value for our shareholders."#ArdentHealthServices #MartyBonick #IPO #Healthcare #ExpansionSource: https://lnkd.in/g9q37KKVUpdate Date: 1 day ago

1

“I would never go back, not for millions of dollars.”Great line from a recent interview with the exceptional Dr. Deborah Moore, M.D.8 years ago she made the leap and started her own DPC practice, and isn’t looking back. I’m very grateful for the courage and tenacity that she and many others have demonstrated by leaving the beaten path and venturing into alternative solutions.Question for the direct-care physicians in my network:What was your experience like making “the jump”?What would you do differently if you could go back and start over? How long did it take before you felt like you were on stable footing again? How much startup capital did it require? (Dr. Moore got away with just $10k.)And most importantly - do you ever miss the way things were? Would you ever be tempted to go back?—P.S. I’ve spoken with a number of DPC docs who are still working on their first 100 members, and I understand that starting a practice from scratch is quite the monumental task.I also know there are many others who are considering making the jump, but have some hesitations.If this is you, please reach out to Dr. Deb and ask about Direct Care Nation. They have some amazing resources to make the business-side of DPC simpler, so that you can focus more energy on the care side of things.If anyone is aware of any other resources, please share them below as well!

20

4 Comments

Agree. I really had no interest in management or even leadership but there was an increasing mismatch between posters on the wall and reality and I mistakenly thought if I went up one more level of the food chain, I could do a better job at explaining to middle managers where they were being short-sighted. Only then I came to realize the middle managers were acting exactly as incentivized per an extractive system where care is a buzzword and margins or profit matter most. Physicians need to return to private practice and we need physician-led and clinician-led innovation and more physician leadership.

10

4 Comments

Teladoc Health CEO Jason Gorevic departs after stock falls 22% in February - MobiHealthNews Teladoc Health CEO Jason Gorevic departs after stock falls 22% in February#TeladocHealthCEO - Teladoc Health CEO Jason Gorevic steps down following a 22% stock decline in February. #ReasonsforDeparture - The departure of Jason Gorevic is attributed to the significant decrease in Teladoc's stock value in February. #InterimCEO - Teladoc appoints Chief Operating Officer Mala Murthy as interim CEO following Gorevic's departure. #StockPerformance - Teladoc's stock fell by 22% in February, leading to the departure of CEO Jason Gorevic. #FutureOutlook - Teladoc Health looks to stabilize its stock performance and regain investorai.mediformatica.com#health #teladoc #revenue #stock #teladochealth #departure #platform #earnings #telehealth #digitalhealth #healthit #healthtech #healthcaretechnology@MediFormatica (https://buff.ly/4aDldYV)

42nd Annual J.P. Morgan Healthcare Conference has come and gone—but despite the packed rooms, there was a major elephant in the room that no one seemed to acknowledge.Not all companies can be winners.In our latest blog post, we dive deep into the industry's pulse to uncover crucial takeaways that were left unspoken. More than 42% of shutdown start-ups launched a product that showed little to no differentiation compared to existing commercial products—we’d say there is a serious problem on our hands.Ready to unlock the secrets that didn't make it to the conference floor? Learn more: https://loom.ly/k0PYh5U

6

1 Comment

After decades of successfully managing a renowned group practice alongside a partner, overseeing six locations, three doctors, and a dedicated team of approximately 45 staff members, Dr. Ernest McDowell initiated plans for the next step of the practice’s evolution. Through his engagement with Diwakar Sinha, Perrin DesPortes and the team at Polaris, we helped increase the group practice’s EBITDA by 40% and shortened the timeline toward the sell-side milestone from over two years to just 18 months. As a result, we were able to transact the sale to DSO Specialty Smile Partners at nearly double the initially expected value. Dr. McDowell is now happy to continue with patient care, but with a growing company much bigger than he alone. According to Dr. McDowell: “The work with Polaris Healthcare has allowed me to enter a new chapter where I can eventually help my company grow without being tied to the chair all the time.” For more details on how we helped improve the value of the business and set up Dr. McDowell for future success, check out the case study. 👇

17

2 Comments

Another week of the journey to building a hospital. Here’s an insight into some of the conversations I’ve been having with investors and how this is similar to the approach to helping people in hospital. (PS: I want to share more about this journey! Would love to know the type of stuff you want to see)

44

4 Comments

We are attending the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco #jpm24 with plethora of quality meetings. Importantly, and as I stated on our last call, we SELLAS Life Sciences Group, Inc. remain steadfast in our belief that the true value of our company lies in the groundbreaking science and the positive impact it can have on patients' lives.We will further focus on four very important items this year: 1.Enhancing Investor Relations: Next to the regular updates we provide through the ordinary quarterly reports, investor presentations, and investor relations events, we will hold periodic “state of the union” calls to address pertinent corporate and clinical updates as they arise; 2.Strategic Partnerships & Licensing Opportunities: We understand the value and power of collaboration and are actively seeking strategic partnerships and licensing opportunities that could accelerate our growth trajectory and could lead to significant strategic outcomes including co-development and co-commercialization, or beyond.We are working closely with Torreya Partners, part of Stifel Financial Corp.; 3.Share Purchase:AllSELLAS executives purchase SELLAS shares through the Employee Stock Purchase Planand we have recently implemented stock ownership guidelines for senior management and Directorsregardingownershipof SELLAS stock; 4.InternalResource Allocation:We will further adjust and refine internal resources this year.As we have done in the past, we will continue to carefully manage our expenditures and we will ask members of our team to take on more responsibility as we weather through the current market conditions.There will be tough decisions to be made, even if it means becoming a leaner organization, while not compromising the integrity of our ongoing studies.We believe that these strategic initiatives, combined with our strong clinical data and commitment to maximizing shareholder value, will position us for long-term success andthe entire SELLAS team is committed to delivering positive outcomes for our shareholders.

44

On 25 January 2024, the Federal Trade Commission (FTC) sued to block Novant Health’s proposed US$320m acquisition of two North Carolina hospitals, Lake Norman Regional Medical Center and Davis Regional Medical Center, from Community Health Systems. This article summarizes the first hospital merger challenge brought by the FTC under the new Merger Guidelines.#MergersAndAcquisitions #MergerControl #Competition #Antitrust #Healthcare #Hospitals